secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001493152-25-013892
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies announces 1-for-30 reverse stock split effective Sept 19, 2025
--------------------------------------------------------------------------------

- 1-for-30 reverse stock split effective at open of trading on Nasdaq on September 19, 2025.
- Post-split outstanding shares approximately 1,338,029; fractional shares paid in cash.
- Reverse split intended to bring Company into compliance with Nasdaq minimum bid price requirement.
- Proportionate adjustments to exercise prices and shares underlying stock options and warrants.
- CUSIP for common stock changes to 09076W307; trading symbol BIAF unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/0001493152-25-013892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer